:max_bytes(150000):strip_icc()/GettyImages-2186511013-35d19a76166947a8a692d8009b279682.jpg?w=780&resize=780,470&ssl=1 "Novo Nordisk Stock Jumps on Early Stage Weight-Loss Drug Trial Results")
KEY TAKEAWAYS Novo Nordisk’s U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for…
Read More »Nordisk
:max_bytes(150000):strip_icc()/GettyImages-2186482541-b5eda0fcf8804c42a77ef0d338260a7e.jpg?w=780&resize=780,470&ssl=1 "Novo Nordisk Sinks on Disappointing Trial Results for Next Gen Weight Loss Drug")
Key Takeaways Novo Nordisk’s U.S.-listed shares tumbled over 19% Friday morning after it released data from a new weight loss…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2161043945-0728ca507d5e45859acdabeec55d352e.jpg?w=780&resize=780,470&ssl=1 "Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs")
Key Takeaways Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies’…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2178012679-b9bb5446194143c688503b2f22a2fa5e.jpg?w=780&resize=780,470&ssl=1 "Novo Nordisk Stock Rises on Earnings Beat, Narrowed Outlook")
Key Takeaways Novo Nordisk’s U.S.-listed shares rose Wednesday morning as third-quarter profits beat estimates and sales of Ozempic and Wegovy…
Read More »:max_bytes(150000):strip_icc()/INV_Hims_Logo_GettyImages-2153332008-bcedcfedc762446b98905bc1f5575a06.jpg?w=780&resize=780,470&ssl=1 "Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025"){kind=logo}
Key Takeaways Hims’ third-quarter results topped expectations, driven in part by revenue from its weight-loss drugs. The company said it…
Read More »:max_bytes(150000):strip_icc()/GettyImages-2169095535-e0b1ad5cf70a42df9bea997a5b976e20.jpg?w=780&resize=780,470&ssl=1 "Novo Nordisk Stock Slips as CEO Faces Senate Inquiry Into Wegovy, Ozempic Prices")
Key Takeaways Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug maker’s…
Read More »:max_bytes(150000):strip_icc()/GettyImages-1830849279-d8dc33a06e6f42d6b81ed4e1a2a96971.jpg?w=780&resize=780,470&ssl=1 "Novo Nordisk Sinks on Obesity Drug Study’s Disappointing Results")
Key Takeaways Novo Nordisk’s U.S.-listed shares lost ground Friday after a Phase 2a trial of the pharmaceutical firm’s latest obesity…
Read More »:max_bytes(150000):strip_icc()/GettyImages-1690265028-388edef8c47f4184bfba3e5deda32f0c.jpg?w=780&resize=780,470&ssl=1 "What You Need To Know Ahead of Novo Nordisk Earnings Wednesday")
<img src='https://www.investopedia.com/thmb/AIq_avuLkl5zDDidl7t0N1Y3JP0=/filters:no_upscale():max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1690265028-388edef8c47f4184bfba3e5deda32f0c.jpg' alt=' Christian Schultz / picture alliance / Getty Images ‘ title=”Novo Nordisk logo on office building”> Christian Schultz…
Read More »